SCHEMBL3384615

SCHEMBL3384615

Cc1cc(C(=O)Nc2cccc(-c3ccc4c(C(=O)O)n[nH]c4c3)c2)no1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.53
ALDH1A1 P00352 2/20 0.53
USP2 O75604 2/20 0.53
FLT3 P36888 1/20 0.47
MAP4K1 Q92918 1/20 0.47
HSD17B10 Q99714 1/20 0.47
RAB9A P51151 6/20 0.46
NPC1 O15118 5/20 0.46
MAPT P10636 3/20 0.46
TP53 P04637 4/20 0.46
GLA P06280 1/20 0.46
HTT P42858 1/20 0.46
AAK1 Q2M2I8 1/20 0.46
CACNA1B Q00975 1/20 0.44
APBA1 Q02410 1/20 0.44
HIF1A Q16665 1/20 0.44
ROCK2 O75116 1/20 0.44
ROCK1 Q13464 1/20 0.44
KDM4E B2RXH2 1/20 0.43
GFER P55789 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3386831 0.91 NPC1 (0.54) SMN1; SMN2ALDH1A1USP2FLT3HSD17B10
SCHEMBL3384708 0.88 MEN1 (0.51) SMN1; SMN2ALDH1A1USP2FLT3MAP4K1
SCHEMBL3384284 0.82 PAK1 (0.53) SMN1; SMN2ALDH1A1USP2FLT3HSD17B10
SCHEMBL3385009 0.78 RAB9A (0.54) SMN1; SMN2ALDH1A1HSD17B10RAB9ANPC1
SCHEMBL3387499 0.76 CNR1 (0.56) FLT3ROCK2
SCHEMBL3384460 0.76 USP2 (0.57) SMN1; SMN2USP2FLT3MAP4K1RAB9A
SCHEMBL3383307 0.75 KDR (0.49) SMN1; SMN2ALDH1A1FLT3MAP4K1RAB9A
SCHEMBL3382786 0.75 NTRK1 (0.56) FLT3RAB9AMAPTHTTROCK2
SCHEMBL8267163 0.75 SMN1; SMN2 (0.88) SMN1; SMN2ALDH1A1USP2HSD17B10RAB9A
SCHEMBL3382214 0.74 HDAC1 (0.49) SMN1; SMN2FLT3MAP4K1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010064875-A2 NOVEL INDAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS PROTEIN KINASE INHIBITORS FOR PROLIFERATIVE DISEASES TREATMENT, AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2010-06-10 WO claimed
WO-2010064875-A2 NOVEL INDAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS PROTEIN KINASE INHIBITORS FOR PROLIFERATIVE DISEASES TREATMENT, AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2010-06-10 WO disclosed